Expression and Clinical Signification of Cytosolic Hyaluronan Levels in Invasive Breast Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2006-05-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-005-9130-7PMID 16791488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)

  2005cited by this paper
• Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer.

  2005cited by this paper
• Hyaluronan-CD44 Interaction with IQGAP1 Promotes Cdc42 and ERK Signaling, Leading to Actin Binding, Elk-1/Estrogen Receptor Transcriptional Activation, and Ovarian Cancer Progression*

  2005cited by this paper
• Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality

  2005cited by this paper
• Tissue-Type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance

  2005cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project

  2004cited by this paper
• Significance of cytosolic hyaluronan levels in gastric cancer.

  2004cited by this paper
• Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan

  2004cited by this paper
• Hyaluronan synthase expression in ovarian cancer.

  2004cited by this paper
• Expression of hyaluronan synthases and hyaluronan in malignant mesothelioma cells.

  2004cited by this paper
• Tree-based model for breast cancer prognostication.

  2004cited by this paper
• Prognostic molecular markers in early breast cancer

  2004cited by this paper
• Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression*

  2003cited by this paper
• Breast Cancer Stromal Myxoid Changes Are Associated with Tumor Invasion and Metastasis: A Central Role for Hyaluronan

  2003cited by this paper
• RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.

  2003cited by this paper
• Clinical implications of urokinase and tissue type plasminogen activators and their inhibitor (PAI-1) in breast cancer tissue.

  2002cited by this paper
• Análisis del contenido citosólico de la proteína pS2 en el cáncer de mama

  2002cited by this paper
• Hyaluronan and Homeostasis: A Balancing Act*

  2002cited by this paper
• Signaling Properties of Hyaluronan Receptors*

  2002cited by this paper
• [Analysis of the cytosolic content of the pS2 protein in breast cancer].

  2002cited by this paper
• Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice.

  2002cited by this paper
• High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.

  2000cited by this paper
• Hyaluronic acid as prognostic marker in resectable colorectal cancer

  2000cited by this paper
• CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration*

  2000cited by this paper
• Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

  2000cited by this paper
• Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate

  1999cited by this paper
• Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

  1999cited by this paper
• Hyaluronan: its nature, distribution, functions and turnover

  1997cited by this paper
• Expression of hyaluronan in benign and malignant breast lesions

  1997cited by this paper
• CD44 and the adhesion of neoplastic cells.

  1997cited by this paper
• pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

  1996cited by this paper
• Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers.

  1996cited by this paper
• Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors.

  1996cited by this paper
• Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression.

  1996cited by this paper
• The role of hyaluronan in tumour neovascularization (review)

  1995cited by this paper
• Synthesis of stromal glycosaminoglycans in response to injury

  1995cited by this paper
• Hyaluronan on the surface of tumor cells is correlated with metastatic behavior.

  1995cited by this paper
• The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells

  1994cited by this paper
• Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma.

  1993cited by this paper
• Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

  1993cited by this paper
• Biology and biochemistry of proteinases in tumor invasion.

  1993cited by this paper
• Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non‐invasive areas

  1992cited by this paper
• Prognostic relevance of serum hyaluronan levels in patients with breast cancer

  1992cited by this paper
• Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.

  1991cited by this paper
• Hyaluronan and its binding proteins, the hyaladherins.

  1990cited by this paper
• Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8‐year survival for node‐negative invasive breast cancer patients

  1990cited by this paper
• Clinico-histochemical studies on type 4 carcinoma of the stomach—With special reference to mucopolysaccharides and sialic acid in tumor tissue

  1989cited by this paper
• Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

  1988cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7.

  1984cited by this paper
• Hyaluronate is synthesized at plasma membranes.

  1984cited by this paper
• Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis.

  1984cited by this paper
• Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis

  1979cited by this paper
• Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma.

  1979cited by this paper
• Glycosaminoglycan Synthesis by Wilms' Tumor

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Variation in glycosaminoglycan components of breast tumors.

  1976cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients

  2022cites this paper
• Type-3 Hyaluronan Synthase Attenuates Tumor Cells Invasion in Human Mammary Parenchymal Tissues

  2021cites this paper
• The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity

  2020cites this paper
• Hyaluronic acid predicts poor prognosis in breast cancer patients

  2020cites this paper
• Prevention of Breast Cancer in Patients with Siliconomas

  2019cites this paper
• MMP11 expression in intratumoral inflammatory cells in breast cancer

  2019cites this paper
• Progesterone – promoter or inhibitor of breast cancer

  2013cites this paper
• A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology?

  2012cites this paper
• Early clinical experience of hyaluronic acid gel for breast enhancement.

  2011cites this paper
• Breast cancer and the stromal factor. The "prometastatic healing process" hypothesis.

  2011cites this paper
• Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast

  2010cites this paper
• HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.

  2010cites this paper
• Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate

  2009cites this paper
• Expression of CD44s, CD44v6, and Hyaluronan Across the Spectrum of Normal-hyperplasia-carcinoma in Breast

  2008cites this paper
• Indigofera suffruticosa Mill: um meio terapêutico alternativo anti-câncer

  2007cites this paper
• Caractérisation des interactions glycosaminoglycannes/protéines dans le but de développer des molécules d'intérêt thérapeutique : exemples de l'Endocan et de l'interféron gamma

  2007cites this paper
• Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation

  2007cites this paper
• Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.

  2007cites this paper
• Indigofera suffruticosa: An Alternative Anticancer Therapy

  2006cites this paper